Invention Grant
- Patent Title: Bortezomib compositions
-
Application No.: US18456759Application Date: 2023-08-28
-
Publication No.: US12005069B2Publication Date: 2024-06-11
- Inventor: Srikanth Sundaram , Daniel Charles Stewart
- Applicant: MAIA Pharmaceuticals, Inc.
- Applicant Address: US NJ Princeton
- Assignee: MAIA PHARMACEUTICALS, INC.
- Current Assignee: MAIA PHARMACEUTICALS, INC.
- Current Assignee Address: US NJ Princeton
- Agency: Blank Rome LLP
- Main IPC: A61K31/69
- IPC: A61K31/69 ; A61K9/00 ; A61K9/08 ; A61K31/198 ; A61K31/4439 ; A61K31/573 ; A61K45/06 ; A61K47/02 ; A61K47/12 ; A61K47/18 ; A61K47/20 ; A61K47/26 ; A61K47/40 ; A61P35/00
Abstract:
The present disclosure relates to ready-to-use liquid aqueous bortezomib compositions bortezomib and pharmaceutical excipients. Other aspects include methods of preparing such ready-to-use liquid aqueous bortezomib compositions, and methods of using such ready-to-use liquid bortezomib compositions in therapeutic applications.
Public/Granted literature
- US20230405029A1 BORTEZOMIB COMPOSITIONS Public/Granted day:2023-12-21
Information query
